An Endoplasmic Reticulum (ER)-Targeting DNA Nanodevice for Autophagy-Dependent Degradation of Proteins in Membrane-Bound Organelles.
Caixia X LiuBin WangWeiping P ZhuYufang F XuYangyang Y YangXuhong H QianPublished in: Angewandte Chemie (International ed. in English) (2022)
Targeted protein degradation via proteasomal and lysosomal pathways is a promising therapeutic approach, and proteins in cytoplasm or on the cell membrane can be easily contacted and have become the major targets. However, degradation of disease-related proteins that exist in membrane-bound organelles (MBO) such as the endoplasmic reticulum (ER) remains unsolved due to the membrane limits. Here we describe a DNA nanodevice that shows ER targeting capacity and undergoes new intracellular degradation via the autophagy-dependent pathway. Then the DNA nanostructure functionalized with specific ligands is used to selectively catch ER-localized proteins and then transport them to the lysosome for degradation. Through this technique, the degradation of both exogenous ER-resident protein (ER-eGFP) and endogenous overexpressed molecular chaperone (glucose-regulated protein 78) in cancer cells has been successfully executed with high efficiency.
Keyphrases
- endoplasmic reticulum
- high efficiency
- cancer therapy
- cell death
- single molecule
- circulating tumor
- oxidative stress
- cell free
- protein protein
- endoplasmic reticulum stress
- estrogen receptor
- breast cancer cells
- amino acid
- transcription factor
- binding protein
- skeletal muscle
- drug delivery
- mass spectrometry
- reactive oxygen species
- living cells
- drug induced
- simultaneous determination
- glycemic control